BR9704114A - Processo de tratamento de doenças vasculares progressivas crÈnicas - Google Patents
Processo de tratamento de doenças vasculares progressivas crÈnicasInfo
- Publication number
- BR9704114A BR9704114A BR9704114-9A BR9704114A BR9704114A BR 9704114 A BR9704114 A BR 9704114A BR 9704114 A BR9704114 A BR 9704114A BR 9704114 A BR9704114 A BR 9704114A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- chronic progressive
- pps
- progressive vascular
- vascular diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Abstract
<B>PROCESSO DE TRATAMENTO DE DOENçAS VASCULARES PROGRESSIVAS CRÈNICAS"<D> Processo para tratamento de paciente mamífero sofrendo de doença vascular progressiva crónica (DVPC) caracterizada por formação de cicatriz e/ou fibrose, para deter o progresso da doença e causar a resolução das lesões fibróticas ou cicatrizes já formadas. Dito processo consiste da administração, ao paciente, de uma composição farmacêutica contendo uma quantidade eficaz de polissulfato de pentosan (PPS), ou um sal farmaceuticamente aceitável do mesmo. A via de administração oral é a preferida, com dosagem total diária de PPS ou sal de PPS variante de cerca de 50 a 1200 mg por dia.
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/478,347 US5643892A (en) | 1995-06-07 | 1995-06-07 | Method of treating chronic progressive vascular diseases |
ZA964247A ZA964247B (en) | 1995-06-07 | 1996-05-27 | Method of treating chronic progressive vascular diseases |
EP96917917A EP0809505B1 (en) | 1995-06-07 | 1996-06-03 | Use of pentosan polysulfate for the resolution of scars in chronic progressive vascular diseases |
DE0809505T DE809505T1 (de) | 1995-06-07 | 1996-06-03 | Verfahren zur behandlung chronischer fortschreitender gefässerkrankungen |
NZ309991A NZ309991A (en) | 1995-06-07 | 1996-06-03 | Using pentonsan polysulphate to treat chronic progressive vascular diseases |
AU60300/96A AU699012B2 (en) | 1995-06-07 | 1996-06-03 | Method of treating chronic progressive vascular diseases |
ES96917917T ES2115571T3 (es) | 1995-06-07 | 1996-06-03 | Uso de polisulfato de pentosana para la resolucion de cicatrices en enfermedades vasculares progresivas cronicas. |
PCT/US1996/008367 WO1996040158A1 (en) | 1995-06-07 | 1996-06-03 | Method of treating chronic progressive vascular diseases |
HU9802431A HUP9802431A3 (en) | 1995-06-07 | 1996-06-03 | Pharmaceutical compns. contg. pentosan polysulfate for the treatment of chronic progressive vascular diseases |
IL12121796A IL121217A (en) | 1995-06-07 | 1996-06-03 | Pharmaceutical compositions containing pentosan polysulfate for treating chronic progressive vascular diseases |
CA002210351A CA2210351C (en) | 1995-06-07 | 1996-06-03 | Method of treating chronic progressive vascular diseases |
TW085109390A TW434018B (en) | 1995-06-07 | 1996-08-03 | Pharmaceutical composition for treating chronic progressive vascular diseases |
US08/840,777 US20010005720A1 (en) | 1995-06-07 | 1997-04-16 | Method of treating chronic progressive vascular scarring diseases |
NO19973081A NO313686B1 (no) | 1995-06-07 | 1997-07-02 | Anvendelse av pentosanpolysulfat (PPS) for behandling av kroniske progressive vaskul¶re sykdommer |
BR9704114-9A BR9704114A (pt) | 1995-06-07 | 1997-07-28 | Processo de tratamento de doenças vasculares progressivas crÈnicas |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/478,347 US5643892A (en) | 1995-06-07 | 1995-06-07 | Method of treating chronic progressive vascular diseases |
BR9704114-9A BR9704114A (pt) | 1995-06-07 | 1997-07-28 | Processo de tratamento de doenças vasculares progressivas crÈnicas |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9704114A true BR9704114A (pt) | 2000-06-06 |
Family
ID=25664870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9704114-9A BR9704114A (pt) | 1995-06-07 | 1997-07-28 | Processo de tratamento de doenças vasculares progressivas crÈnicas |
Country Status (14)
Country | Link |
---|---|
US (1) | US5643892A (pt) |
EP (1) | EP0809505B1 (pt) |
AU (1) | AU699012B2 (pt) |
BR (1) | BR9704114A (pt) |
CA (1) | CA2210351C (pt) |
DE (1) | DE809505T1 (pt) |
ES (1) | ES2115571T3 (pt) |
HU (1) | HUP9802431A3 (pt) |
IL (1) | IL121217A (pt) |
NO (1) | NO313686B1 (pt) |
NZ (1) | NZ309991A (pt) |
TW (1) | TW434018B (pt) |
WO (1) | WO1996040158A1 (pt) |
ZA (1) | ZA964247B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010005720A1 (en) * | 1995-06-07 | 2001-06-28 | U.S.A. As Represented By The Secretary Department Of Health And Human Services | Method of treating chronic progressive vascular scarring diseases |
US6255295B1 (en) | 1996-12-23 | 2001-07-03 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue |
UA65587C2 (en) | 1997-10-09 | 2004-04-15 | Baker Norton Pharma | Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus |
DE19747195A1 (de) * | 1997-10-24 | 1999-04-29 | Knoll Ag | Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten |
AR035026A1 (es) | 2000-01-19 | 2004-04-14 | Baker Norton Pharma | Uso de pentosan polisulfato en el tratamiento de ciertas condiciones de la prostata |
EP1906975A4 (en) * | 2005-07-22 | 2010-10-06 | Trf Pharma Inc | METHOD FOR THE TREATMENT OF SICKLE CELL DISEASE AND CONSEQUENCES OF SICKLE CELL DISEASE |
HUE058709T2 (hu) * | 2006-04-03 | 2022-09-28 | Ceva Animal Health Pty Ltd | Stabilizált pentozán-poliszulfát (PPS) készítmények |
WO2010103837A1 (ja) | 2009-03-11 | 2010-09-16 | ゼライス株式会社 | アテローム性動脈硬化症の進行抑制薬・予防薬・血中コレステロール低下薬・機能性食品・特定保健用食品 |
US8871741B2 (en) * | 2010-01-15 | 2014-10-28 | Icahn School Of Medicine At Mount Sinai | Inhibition of TNF-α induced activation of NFKB by pentosan polysulfate |
US9155784B2 (en) | 2011-06-20 | 2015-10-13 | Icahn School Of Medicine At Mount Sinai | Anti-TNF-α therapy for the mucopolysaccharidoses and other lysosomal disorders |
US20130273096A1 (en) * | 2011-10-05 | 2013-10-17 | Bruce A. Daniels | Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients |
EP3842048A4 (en) | 2018-08-20 | 2022-03-30 | ReqMed Company, Ltd. | NOVEL PENTOSAN POLYSULFATE PREPARATION |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4820693A (en) * | 1986-05-22 | 1989-04-11 | Angiogenics, Ltd. | Method and composition for arresting angiogenesis and capillary, cell or membrane leakage |
US4966890A (en) * | 1986-04-04 | 1990-10-30 | Angiogenics, Ltd. | Method and composition for arresting angiogenesis and capillary, cell or membrane leakage |
DE3725554A1 (de) * | 1987-08-01 | 1989-02-09 | Hoechst Ag | Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung |
US5032679A (en) * | 1988-12-15 | 1991-07-16 | Glycomed, Inc. | Heparin fragments as inhibitors of smooth muscle cell proliferation |
EP0466315A3 (en) * | 1990-05-30 | 1992-07-01 | Larrian Gillespie | Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation |
US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
-
1995
- 1995-06-07 US US08/478,347 patent/US5643892A/en not_active Expired - Fee Related
-
1996
- 1996-05-27 ZA ZA964247A patent/ZA964247B/xx unknown
- 1996-06-03 HU HU9802431A patent/HUP9802431A3/hu unknown
- 1996-06-03 EP EP96917917A patent/EP0809505B1/en not_active Expired - Lifetime
- 1996-06-03 CA CA002210351A patent/CA2210351C/en not_active Expired - Fee Related
- 1996-06-03 IL IL12121796A patent/IL121217A/xx not_active IP Right Cessation
- 1996-06-03 DE DE0809505T patent/DE809505T1/de active Pending
- 1996-06-03 WO PCT/US1996/008367 patent/WO1996040158A1/en active IP Right Grant
- 1996-06-03 ES ES96917917T patent/ES2115571T3/es not_active Expired - Lifetime
- 1996-06-03 NZ NZ309991A patent/NZ309991A/en unknown
- 1996-06-03 AU AU60300/96A patent/AU699012B2/en not_active Ceased
- 1996-08-03 TW TW085109390A patent/TW434018B/zh not_active IP Right Cessation
-
1997
- 1997-07-02 NO NO19973081A patent/NO313686B1/no unknown
- 1997-07-28 BR BR9704114-9A patent/BR9704114A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2115571T1 (es) | 1998-07-01 |
CA2210351A1 (en) | 1996-12-19 |
AU6030096A (en) | 1996-12-30 |
AU699012B2 (en) | 1998-11-19 |
IL121217A0 (en) | 1999-10-28 |
IL121217A (en) | 2000-09-28 |
EP0809505B1 (en) | 2003-04-02 |
CA2210351C (en) | 2003-09-23 |
HUP9802431A3 (en) | 2001-06-28 |
DE809505T1 (de) | 1998-05-28 |
EP0809505A1 (en) | 1997-12-03 |
NO973081L (no) | 1997-08-27 |
HUP9802431A2 (hu) | 1999-02-01 |
WO1996040158A1 (en) | 1996-12-19 |
NZ309991A (en) | 2001-03-30 |
US5643892A (en) | 1997-07-01 |
TW434018B (en) | 2001-05-16 |
NO313686B1 (no) | 2002-11-18 |
ES2115571T3 (es) | 2003-09-01 |
NO973081D0 (no) | 1997-07-02 |
EP0809505A4 (en) | 1998-07-01 |
ZA964247B (en) | 1996-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180319837A1 (en) | Methods and compositions for treating and/or preventing parkinson's disease | |
Müller-Fassbender | Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis | |
BR9704114A (pt) | Processo de tratamento de doenças vasculares progressivas crÈnicas | |
CA2093806A1 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
EA200501496A1 (ru) | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения | |
RU2007104095A (ru) | Применение твердой пероральной дозировочной композиции пролонгированного действия для приготовления лекарственных средств | |
HUP9602215A2 (hu) | 4-Klór-5-(imidazolin-2-il-amino)-6-metoxi-2-metil-pirimidin alkalmazása megvonási tünetek kezelésére alkalmas gyógyszerkészítmény előállítására | |
IL124977A0 (en) | Oral administration of effective amounts of forms of hyaluronic acid | |
PT1212060E (pt) | Utilizacao de nicotina ou dos seus derivados e de l-dopa num medicamento para o tratamento de doencas neurologicas, em especial a doenca de parkinson | |
EP1369119B1 (en) | Il-12 expression controlling agents | |
Perkins | Apnea with intramuscular colistin therapy | |
JPH11514967A (ja) | 粘膜炎症の治療用医薬の製造のためのヒアルロン酸およびnsaidの使用 | |
EP1655026A1 (en) | Solid pharmaceutical formulations comprising diacereine and meloxicam | |
BR9607964A (pt) | Processo de preparação de um medicamento para tratar doença inflamatória do intestino | |
CA2274510A1 (en) | Treatment of osteoarthritis by administering poly-n-acetyl-d-glucosamine | |
JPH06329541A (ja) | 糖尿病性腎症治療用スロデキサイド含有医薬 | |
JPS59501460A (ja) | カフェインを含んで成る改良された鎮痛及び抗炎症組成物並びにその使用方法 | |
BR9809396A (pt) | Método de tratamento de doenças de cicatrização vascular progressivas | |
HU227067B1 (en) | Use of hyaluronic acid for preparing pharmaceutical compositions to prevent arterial restenosis | |
AR002727A1 (es) | El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion. | |
DE3688787D1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
EP1024807B1 (en) | Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment | |
US5876751A (en) | Antispasmodic and antinflammatory composition and a process for the manufacture thereof | |
Solankar et al. | Chronobiological and chronopharmacological studies of ketoprofen and its solid dispersion form using adjuvant arthritis model in rats. | |
JP4032437B2 (ja) | 痴呆治療剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ARTIGO 8O DA LPI |
|
B15K | Others concerning applications: alteration of classification |
Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 31/715; A61K 31/725. Ipc: A61K 31/737 (2006.01) Ipc: A61K 31/737 (2006.01) |